A prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a new lesion localization device

American Journal of Surgery

Volumn 184, Issue 4, 2002, Pages 318-321

  Israel, Philip ^a   Gittleman, Mark ^b   Fenoglio, Michael ^c   Stocks, Lewis ^d   Gardner, Robert ^e   Whitworth, Patrick ^f   Parker, Steve ^c   Kusnick, Catherine ^g  

^a Breast Center   (United States)

^b Sacred Heart Hospital   (United States)

^c INVISION SALLY JOBE   (United States)

^d Raleigh Community Hospital   (United States)

^e Center for Breast Surgery   (United States)

^f Baptist Hospital Nashville   (United States)

^g SenoRx   (United States)

Author keywords

Breast biopsy; Lumpectomy; Margin status; Reexcision; Wire localization

Indexed keywords

ACCURACY; ARTICLE; BLEEDING; BREAST CARCINOMA; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TIME; WIRE FIXATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; CALCINOSIS; EQUIPMENT AND SUPPLIES; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; REOPERATION; TREATMENT OUTCOME;

EID: 0036804720     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)00954-6     Document Type: Article

References (10)

1. Jackman R.J., Marzoni F.A. Needle-localized breast biopsy why do we fail? Radiology. 204:1997;677-684.
2. Israel P.Z., Fine R.E. Stereotactic needle biopsy for occult breast lesions a minimally invasive alternative. Am Surg. 61:1995;87-91.
3. Lind D.S., Minter R., Steinbach B., et al. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res. 78:1998;23-26.
4. Yim J.H., Barton P., Weber B., et al. Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. Ann Surg. 223:1996;688-700.
5. Kaufman C.S., Delbecq R., Jacobson L. Excising the reexcision stereotactic core-needle biopsy decreases need for reexcision of breast cancer. World J Surg. 22:1998;1023-1028.
6. Cox C.E., Reintgen D.S., Nicosia S.V., et al. Analysis of residual cancer after diagnostic breast biopsy an argument for fine-needle aspiration cytology. Ann Surg Oncol. 2:1995;201-206.
7. Hollander J.E., Blasko B., Singer A.J., et al. Poor correlation of short- and long-term cosmetic appearance of repaired lacerations. Acad Emerg Med. 2:1995;983-987.
8. Mokbel K., Ahmed M., Nash A., Sacks N. Reexcision operations in nonpalpable breast cancer. J Surg Oncol. 58:1995;225-228.
9. DiBiase S.J., Komarnicky L.T., Schwartz G.F., et al. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer. 82:1998;2212-2220.
10. Papa M.Z., Klein E., Davidson B., et al. The effect of anesthesia type on needle localization breast biopsy another point of view. Am J Surg. 171:1996;242-243.